Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 20 de 55 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Psaty B M, Furberg CD. COX-inhibitors - lessons in drug safety. N Engl J Med 2005;352:1133-5. [Ref.ID 73279]
2.Tiene citas relacionadas
Cushman M, Prentice R, Psaty B M, Rosendaal F R. Estrogen plus progestin and risk of venous thrombosis. In reply. JAMA 2005;293:1322-3. [Ref.ID 73189]
3. Cita con resumen
Schelleman H, Stricker BHCH, de Boer A, Kroon AA, Verschuren MWM, Van Duijn CM, Psaty B M, Klungel OH. Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 2004;64:1801-16. [Ref.ID 72776]
6.Tiene citas relacionadas Cita con resumen
Smith NL, Heckbert SR, Lemaitre RN, Reiner A P, Lumley T, Weiss NS, Larson EB, Rosendaal F R, Psaty B M. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004;292:1581-7. [Ref.ID 71587]
7.Tiene citas relacionadas Cita con resumen
Cushman M, Kuller LH, Prentice R, Rodabough R J, Psaty B M, Stafford RS, Sidney S, Rosendaal F R, for the Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004;292:1573-80. [Ref.ID 71586]
8.Tiene citas relacionadas Cita con resumen
Psaty B M, Furberg CD. Contemplating ACTION - long-acting nifedipine in stable angina. Lancet 2004;364:817-8. [Ref.ID 71261]
9. Cita con resumen
10.Tiene citas relacionadas Cita con resumen
Stricker BHCH, Psaty B M. Detection, verification, and quantification of adverse drug reactions. BMJ 2004;329:44-7. [Ref.ID 70506]
11.Tiene citas relacionadas Cita con resumen
Psaty B M, Lumley T, Gurberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. Health outcomes associated with various antihypertensive therapies uses as first-line agents. A network meta-analysis. JAMA 2003;289:2534-44. [Ref.ID 66345]
12.Tiene citas relacionadas
Psaty B M, Rennie D. Stopping medical research to save money. A broken pact with researchers and patients. JAMA 2003;289:2128-31. [Ref.ID 65829]
13.
Cooper RS, Psaty B M. Genomics and medicine: distraction, incremental progress, or the dawn of a new age?. Ann Intern Med 2003;138:576-80. [Ref.ID 65598]
14.Tiene citas relacionadas Cita con resumen
Lemaitre RN, Heckbert SR, Psaty B M, Smith NL, Kaplan RC, Longstreth WT. Hormone replacement therapy and associated risk of stroke in postmenopausal women. Arch Intern Med 2002;162:1954-60. [Ref.ID 63450]
16.
Klungel OH, Heckbert SR, de Boer A, Leufkens HGM, Sullivan SD, Fishman PA, Veenstra DL, Psaty B M. Lipid-lowering drug use and cardiovascular events after myocardial infarction. Ann Pharmacother 2002;36:751-7. [Ref.ID 61836]
17. Cita con resumen
Psaty B M, Smith NL, Heckbert SR, Vos HL, Lemaitre RN, Reiner A P, Siscovick DS, Bis J, Lumley T, Longstreth WT, Rosendaal F R. Diuretic therapy, the alfa-adducin gene variant, and the risk of myocardial infarction of stroke in persons with treated hypertension. JAMA 2002;287:1680-9. [Ref.ID 61453]
19.Tiene citas relacionadas
Klungel OH, Leufkens HGM, de Boer A, Longstreth WT, Kaplan RC, Smith NL, Psaty B M. Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs. In reply. Arch Intern Med 2001;161:2153. [Ref.ID 58631]
20.
Heckbert SR, Kaplan RC, Weiss NS, Psaty B M, Lin D, Furberg CD, Starr JR, Anderson GD, LaCroix AZ. Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. Arch Intern Med 2001;161:1709-13. [Ref.ID 58522]
Seleccionar todas
 
 1 a 20 de 55 siguiente >>